UNSPSC 51341702: Xenygloxal

This classification denotes an antiviral agent and antimicrobial with the molecular formula C16H10O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3C2T3HG40E, chemically known as 4,4-diphenyldicarboxaldehyde but generally known as xenygloxal, which bears US NIH Compound Identifier 239061. European Medicines Agency schedules Xenygloxal in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00106MIG.

UNSPSC 51341702 Xenygloxal, a Commodity code, shows little relevant recent activity aligned with its nominal scope. The two most recent state and local opportunities tagged under this code reflect pharmaceutical procurement — antibiotic tablets (Doxycycline Hyclate and Ciprofloxacin) and emergency medical supplies (Naloxone and drug deactivation systems) — rather than the specific chemical compound the code nominally describes. State and local governments do procure pharmaceuticals, medical supplies, and emergency response items through their purchasing offices, but the mismatch between the code's stated product and the actual goods being solicited suggests either misclassification in the source data or that this code sees limited current use for direct procurement activity.

The Illinois Department of Public Health awarded a piggyback pharmaceutical contract to Chartwell Rx LLC on August 28, 2026, valued at $2,999,999.11 over three years (initial 12-month term plus two renewal options) through the MMCAP Infuse cooperative purchasing vehicle; the award was made on an Invitation for Bid basis and is now closed. Separately, Seminole County, Florida issued an IFB on June 30, 2026, seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries, though the response deadline listed in the source (July 26, 2023) predates the posting date and suggests data quality issues. Activity under this code is sparse and geographically limited to Florida and Illinois in the recent record; business development professionals should verify the code's applicability to their product or service line before pursuing opportunities tagged under it.